Researchers continue to excited about Retatrutide , a novel dual agonist showing remarkable outcomes in initial trials for size loss . It works by targeting two hormones : GLP-1 and GIP, these, when engaged , help control cravings and improve metabolism . Initial findings indicate considerable weight loss and possible advantages for people facing o